Literature DB >> 15232664

Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.

Melih O Babaoglu, Omer Karadag, Yutaka Saikawa, Kadri Altundag, Tamer Elkiran, Umit Yasar, Atila Bozkurt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15232664     DOI： 10.1007/s00228-004-0790-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: effect on drug efflux.

Authors:  S A Terlouw; R Masereeuw; F G Russel; D S Miller
Journal:  Mol Pharmacol       Date:  2001-06       Impact factor: 4.436

2.  Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.

Authors:  K Nachbaur; O Dietze; M Herold; J Thaler; H Braunsteiner; W Vogel
Journal:  Eur J Haematol       Date:  1992-10       Impact factor: 2.997

3.  beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.

Authors:  M E Ganapathy; W Huang; D P Rajan; A L Carter; M Sugawara; K Iseki; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

4.  Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome.

Authors:  M Tanaka; H Kanamori; S Yamaji; A Mishima; H Fujita; S Fujisawa; T Murata; H Koharazawa; M Matsuzaki; H Mohri
Journal:  Anticancer Drugs       Date:  1999-03       Impact factor: 2.248

5.  Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia.

Authors:  J L Yang; J C White; R L Capizzi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Potentiation of methotrexate toxicity by dipyridamole.

Authors:  J A Nelson; S Drake
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

7.  A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

Authors:  Lijie Yue; Yutaka Saikawa; Kazuhisa Ota; Motohiro Tanaka; Ryosei Nishimura; Takahiro Uehara; Hideaki Maeba; Takashi Ito; Takuma Sasaki; Shoichi Koizumi
Journal:  Pharmacogenetics       Date:  2003-01

8.  Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.

Authors:  J L Yang; J C White; R L Capizzi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  8 in total
  1 in total

1.  Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients.

Authors:  Mei-Ling Liu; Li-Yin Chien; Cheng-Jeng Tai; Kuan-Chia Lin; Chen-Jei Tai
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-07       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.